This study tested the hypothesis that the expression of CD112 and CD155 (DNAM‐1 ligands) on leukemic blasts induces a decreased expression of the activating receptor DNAM‐1 on natural killer (NK) cells from acute myeloid leukemia (AML) patients. DNAM‐1 is a co‐receptor involved in the activation …